Turn recording back on
Interactions between APP secretases and inflammatory mediators.
Sastre M, Walter J, Gentleman SM.
J Neuroinflammation. 2008 Jun 18;5:25. Review.
PMID: 18564425 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.
Rossner S, Sastre M, Bourne K, Lichtenthaler SF.
Prog Neurobiol. 2006 Jun;79(2):95-111. Epub 2006 Aug 14. Review.
PMID: 16904810 [PubMed - indexed for MEDLINE]
Related Articles
Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y, Lee DY, Jiang L, Ma Z, Schachter SC, Lemere CA.
Neuroscience. 2007 Dec 5;150(2):386-95. Epub 2007 Sep 14.
PMID: 17945434 [PubMed - indexed for MEDLINE]
Inhibition of Abeta production by NF-kappaB inhibitors.
Paris D, Patel N, Quadros A, Linan M, Bakshi P, Ait-Ghezala G, Mullan M.
Neurosci Lett. 2007 Mar 19;415(1):11-6. Epub 2006 Dec 27.
PMID: 17223266 [PubMed - indexed for MEDLINE]
Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.
Sambamurti K, Greig NH, Lahiri DK.
Neuromolecular Med. 2002;1(1):1-31. Review.
PMID: 12025813 [PubMed - indexed for MEDLINE]
BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R.
J Mol Neurosci. 2004;23(1-2):105-14. Review.
PMID: 15126696 [PubMed - indexed for MEDLINE]
Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease.
Jans DM, Martinet W, Van De Parre TJ, Herman AG, Bult H, Kockx MM, De Meyer GR.
Cardiovasc Hematol Disord Drug Targets. 2006 Mar;6(1):21-34. Review.
PMID: 16724933 [PubMed - indexed for MEDLINE]
The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
J Mol Neurosci. 2001 Oct;17(2):157-70. Review.
PMID: 11816789 [PubMed - indexed for MEDLINE]
The non-amyloidogenic pathway: structure and function of alpha-secretases.
Kojro E, Fahrenholz F.
Subcell Biochem. 2005;38:105-27. Review.
PMID: 15709475 [PubMed - indexed for MEDLINE]
Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G, Zhu A, Holsinger RM, Masters CL, Li QX.
J Neurosci Res. 2003 Nov 1;74(3):386-92.
PMID: 14598315 [PubMed - indexed for MEDLINE]
beta-Secretase, APP and Abeta in Alzheimer's disease.
Subcell Biochem. 2005;38:79-103. Review.
PMID: 15709474 [PubMed - indexed for MEDLINE]
Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I, Arbel M, Solomon B.
Neurodegener Dis. 2007;4(5):392-402. Epub 2007 May 25.
PMID: 17536186 [PubMed - indexed for MEDLINE]
Molecular rationale for the pharmacological treatment of Alzheimer's disease.
Zimmermann M, Gardoni F, Di Luca M.
Drugs Aging. 2005;22 Suppl 1:27-37. Review.
PMID: 16506440 [PubMed - indexed for MEDLINE]
Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation.
Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT.
J Neuroinflammation. 2008 Aug 29;5:37.
PMID: 18759972 [PubMed - indexed for MEDLINE]
Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
Brijbassi S, Amtul Z, Newbigging S, Westaway D, St George-Hyslop P, Rozmahel RF.
Neurobiol Dis. 2007 Feb;25(2):291-6. Epub 2006 Oct 27.
PMID: 17071095 [PubMed - indexed for MEDLINE]
Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides.
Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG, Perez-Polo JR.
J Neurosci Res. 2007 May 1;85(6):1194-204.
PMID: 17385716 [PubMed - indexed for MEDLINE]
The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis.
Hoe HS, Cooper MJ, Burns MP, Lewis PA, van der Brug M, Chakraborty G, Cartagena CM, Pak DT, Cookson MR, Rebeck GW.
J Neurosci. 2007 Oct 3;27(40):10895-905.
PMID: 17913923 [PubMed - indexed for MEDLINE]
Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.
He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C, Staufenbiel M, Li R, Shen Y.
J Cell Biol. 2007 Aug 27;178(5):829-41.
PMID: 17724122 [PubMed - indexed for MEDLINE]
Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O'Banion K, Klockgether T, Van Leuven F, Landreth GE.
Brain. 2005 Jun;128(Pt 6):1442-53. Epub 2005 Apr 7.
PMID: 15817521 [PubMed - indexed for MEDLINE]
Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM.
Acta Neuropathol. 2006 Aug;112(2):163-74. Epub 2006 Jun 1.
PMID: 16865398 [PubMed - indexed for MEDLINE]